心房颤动合并冠心病患者行经皮冠状动脉介入术后3种抗栓治疗疗效比较

A comparative study on three antithrombotic treatments following percutaneous coronary intervention in patients with atrial fibrillation and coronary heart disease

  • 摘要: 目的 比较心房颤动合并冠心病患者行经皮冠状动脉介入术(PCI)后3种抗栓治疗的效果。 方法 选取90例行PCI治疗的心房颤动合并冠心病患者为研究对象,根据随机数字表法分为Ⅰ组(n=30, 华法林联合氯吡格雷)、Ⅱ组(n=30, 阿司匹林联合氯吡格雷)、Ⅲ组(n=30, 华法林、阿司匹林联合氯吡格雷)。比较3组临床疗效、心房颤动发作情况。 结果 Ⅲ组患者临床治疗总有效率显著高于Ⅰ组、Ⅱ组(P<0.05); 干预后, Ⅲ组患者心房颤动发作频率低于Ⅰ组、Ⅱ组, 每次发作持续时间亦短于Ⅰ组、Ⅱ组, ST段压低程度低于Ⅰ组、Ⅱ组, 差异均有统计学意义(P<0.05)。 结论 心房颤动合并冠心病患者行PCI后接受华法林、阿司匹林联合氯吡格雷治疗的临床疗效显著,其心房颤动发作频率降低,持续时间缩短,发作时ST段压低程度降低。

     

    Abstract: Objective To compare the effect of three antithrombotic treatments following percutaneous coronary intervention(PCI)in patients with atrial fibrillation and coronary heart disease. Methods A total of 90 patients with atrial fibrillation and coronary heart disease treated by PCI were selected as study objects, and randomly divided into group Ⅰ(n=30, treated by warfarin combined with clopidogrel), group Ⅱ(n=30, treated by aspirin combined with clopidogrel), and group Ⅲ(n=30, treated by warfarin, aspirin combined with clopidogrel). The clinical efficacy and the attack of atrial fibrillation were compared. Results The total effective rate in the group Ⅲ was significantly higher than that in the group Ⅰ and the group Ⅱ(P<0.05); after intervention, the frequency of atrial fibrillation attack in the group Ⅲ was significantly lower than that in the group Ⅰ and the group Ⅱ, the duration of atrial fibrillation attack was significantly shorter than that in the group Ⅰ and the group Ⅱ, and the decreased degree of ST segment was significantly lower than that in the group Ⅰ and the group Ⅱ(P<0.05). Conclusion After PCI, patients with atrial fibrillation and coronary heart disease accepting warfarin, aspirin and clopidogrel have better clinical effect, and they have reduced frequency of atrial fibrillation attack, shortened onset duration, and decreased degree of ST segment depression.

     

/

返回文章
返回